High doses of Alzheimer’s drug Aricept should be banned, Public Citizen says
Sunday, May 22nd, 2011High doses of the Alzheimer’s drug Aricept should be banned because they are no more effective than low doses and have a sharply increased risk of adverse effects, the advocacy group Public Citizen and a Johns Hopkins University geriatrician said Wednesday in a petition to the Food and Drug Administration. ... continue reading